1. Home
  2. AVTX vs EDAP Comparison

AVTX vs EDAP Comparison

Compare AVTX & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • EDAP
  • Stock Information
  • Founded
  • AVTX 2011
  • EDAP 1979
  • Country
  • AVTX United States
  • EDAP France
  • Employees
  • AVTX N/A
  • EDAP N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AVTX Health Care
  • EDAP Health Care
  • Exchange
  • AVTX Nasdaq
  • EDAP Nasdaq
  • Market Cap
  • AVTX 88.4M
  • EDAP 81.6M
  • IPO Year
  • AVTX 2015
  • EDAP 1997
  • Fundamental
  • Price
  • AVTX $7.73
  • EDAP $2.63
  • Analyst Decision
  • AVTX Strong Buy
  • EDAP Strong Buy
  • Analyst Count
  • AVTX 4
  • EDAP 1
  • Target Price
  • AVTX $33.00
  • EDAP $19.00
  • AVG Volume (30 Days)
  • AVTX 54.4K
  • EDAP 38.2K
  • Earning Date
  • AVTX 03-28-2025
  • EDAP 03-26-2025
  • Dividend Yield
  • AVTX N/A
  • EDAP N/A
  • EPS Growth
  • AVTX N/A
  • EDAP N/A
  • EPS
  • AVTX N/A
  • EDAP N/A
  • Revenue
  • AVTX $820,000.00
  • EDAP $70,722,730.00
  • Revenue This Year
  • AVTX N/A
  • EDAP $6.96
  • Revenue Next Year
  • AVTX N/A
  • EDAP $15.53
  • P/E Ratio
  • AVTX N/A
  • EDAP N/A
  • Revenue Growth
  • AVTX N/A
  • EDAP 12.17
  • 52 Week Low
  • AVTX $4.18
  • EDAP $2.00
  • 52 Week High
  • AVTX $34.46
  • EDAP $8.50
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 47.38
  • EDAP 64.95
  • Support Level
  • AVTX $7.42
  • EDAP $2.46
  • Resistance Level
  • AVTX $8.50
  • EDAP $2.69
  • Average True Range (ATR)
  • AVTX 0.69
  • EDAP 0.15
  • MACD
  • AVTX 0.06
  • EDAP 0.03
  • Stochastic Oscillator
  • AVTX 38.90
  • EDAP 79.65

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

Share on Social Networks: